The FDA has been petitioned to finalise its November 1999 proposal that food manufacturers must reveal the presence of so-called “phantom fat” in processed foods. It has also been slammed for proposing to group trans fats with saturated fats on product labels.

Based in Washington DC, The Center for Science in the Public Interest (CSPI) has campaigned on the issue since 1994 and sent a letter to the FDA on Wednesday demanding consumers be made aware of the trans fats in their foods.

Created when vegetable oils are processed to make them more stable and solid, trans fats are widely used as a popular alternative to saturated fats, and are found in margarine, baked goods and processed foods.

According to several new scientific studies however, trans fat might result in similar consequences for health as saturated fats, and CSPI executive director Dr. Michael Jacobson argued in the letter that labelling them in a food product might save between 2,100 to 5,600 consumers from heart disease every year.

“Considering how many lives labelling of trans fat could save annually and the overwhelmingly favourable cost/benefit ratio, we respectfully urge you to take prompt action to ensure that trans fats are labelled,” the letter continues.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The FDA declined to comment on any pending regulation or the trans fat petition.